Mirum Pharmaceuticals: Raymond James raises target price to $189 from $183
MIRM•Raymond James raised its target price for Mirum Pharmaceuticals to $189 from $183.
Related News
From Iran to trade: how the US midterms impact the rest of the world
SPY•
Huron Consulting Group Inc.: Wedbush raises target price to $220 from $160
HURN•
Neuronetics Q3 revenue $41.962 million vs. IBES estimate $40.4 million
STIM•
TD Cowen cuts Revolve Group target price to $25 from $31
RVLV•
The AI boom teeters on a capital balancing act
QQQ•